New York State Common Retirement Fund Aerovate Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 4,294 shares of AVTE stock, worth $11,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,294
Previous 4,294
-0.0%
Holding current value
$11,250
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AVTE
# of Institutions
77Shares Held
28.4MCall Options Held
116KPut Options Held
26.6K-
Ra Capital Management, L.P. Boston, MA9.19MShares$24.1 Million0.27% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA3.76MShares$9.85 Million0.74% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$5.87 Million0.61% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.71 Million0.46% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$3.7 Million0.05% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $64.1M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...